Historical record - last NADAC effective date: 8/17/2016
Product Information
GLIMEPIRIDE 2 MG TABLET is a generic product labeled by Micro Labs Limited, priced at $0.1223 per EA under NDC 42571010105. Its NADAC has been published 129 times since Mar 19, 2014.
FDA first approved this application on Jun 29, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Glimepiride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
2 mg/1
Manufacturer
Micro Labs LimitedNDC
42571010105
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/17/2016
Active Ingredients
GLIMEPIRIDEApproval Type
Generic (ANDA)
FDA Application
ANDA091220FDA Approved
6/29/2012
TE Code
AB
On Market Since
6/13/2013
Pharmacological Classes
Price Statistics
The NADAC for GLIMEPIRIDE 2 MG TABLET has been published 129 times since Mar 19, 2014, and over the history we have for it it has risen 214.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1223 per EA |
|---|---|
| All-time high | $0.1433 (Jan 13, 2016) |
| All-time low | $0.0339 (Jun 18, 2014) |
| Median price | $0.0761 |
| Average price | $0.0855 |
| Largest weekly change | +85.6% (Feb 18, 2015) |
| Weeks tracked | 129 |
| Tracking since | Mar 19, 2014 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+214.4%
Last surveyed Aug 31, 2016 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 71% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of GLIMEPIRIDE 2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GLIMEPIRIDE 2 MG TABLET, manufactured by Micro Labs Limited, is $0.1223 per EA (NDC 42571010105), effective Aug 31, 2016.
How has the price of GLIMEPIRIDE 2 MG TABLET changed over time?
Over the history we have for it, the NADAC for GLIMEPIRIDE 2 MG TABLET has risen 214.4%. It has been tracked across 129 weekly CMS publications since Mar 19, 2014.
What are the highest and lowest recorded NADAC prices for GLIMEPIRIDE 2 MG TABLET?
Since Mar 19, 2014, the NADAC for GLIMEPIRIDE 2 MG TABLET has ranged from a low of $0.0339 (Jun 18, 2014) to a high of $0.1433 (Jan 13, 2016), with a median of $0.0761 per EA.
Are there cheaper alternatives to GLIMEPIRIDE 2 MG TABLET?
Yes. 10 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, GLIMEPIRIDE 2 MG TABLET, is $0.0358 per EA — about 71% below GLIMEPIRIDE 2 MG TABLET.
Who manufactures GLIMEPIRIDE 2 MG TABLET?
GLIMEPIRIDE 2 MG TABLET (NDC 42571010105) is labeled by Micro Labs Limited, and CMS classifies it as a generic product.